{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:03:16Z","timestamp":1787580196568,"version":"build-2736575974"},"reference-count":33,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Cancer"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Malignant mesothelioma is an aggressive cancer and has a poor prognosis. Here, we analyzed the feasibility, molecular and gender aspects of targeted therapy recommendations for malignant mesothelioma based on the individual molecular tumor profile.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this single\u2010center, real\u2010world retrospective analysis of our platform for precision medicine, we evaluated the molecular profiling of malignant mesothelioma in 14 patients, including nine men and five women. Tumor samples of the patients were examined with a 50 gene next\u2010generation sequencing (NGS) panel, immunohistochemistry, and fluorescence in situ hybridization, to detect possible molecular aberrations which may be targeted by off\u2010label therapy custom\u2010tailored to the individual patient.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, we identified 11 mutations in six of the 14 patients, including <jats:italic>BAP1<\/jats:italic>, <jats:italic>FANCA<\/jats:italic>, <jats:italic>NF1<\/jats:italic>, <jats:italic>NF2<\/jats:italic>, <jats:italic>PD\u2010L1<\/jats:italic>, <jats:italic>RAD52D<\/jats:italic>, <jats:italic>SETD2<\/jats:italic>, <jats:italic>SRC<\/jats:italic>, and <jats:italic>TP53<\/jats:italic>. No mutation was detected in eight of the 14 patients. Targeted therapy was recommended for 11 out of the 14 patients. All recommendations were mainly based on the molecular characteristics determined by immunohistochemistry. Targeted therapy recommendations were significantly more often for men than women due to gender\u2010specific differences in PDGFR\u03b1 expression. Eventually, four patients received the targeted therapy, of whom one patient subsequently achieved stable disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our observations suggest that a molecular\u2010guided treatment approach is feasible for the management of advanced malignant mesothelioma. Our analysis revealed gender specific differences in PDGFR\u03b1 expression that should be further evaluated in clinical trials.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1759-7714.13491","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T22:42:02Z","timestamp":1590100922000},"page":"1979-1988","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Gender differences in molecular\u2010guided therapy recommendations for metastatic malignant mesothelioma"],"prefix":"10.1111","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0927-6498","authenticated-orcid":false,"given":"Hossein","family":"Taghizadeh","sequence":"first","affiliation":[{"name":"Division of Clinical Oncology, Department of Medicine I Medical University of Vienna  Vienna Austria"},{"name":"Comprehensive Cancer Center Medical University of Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Z\u00f6chbauer\u2010M\u00fcller","sequence":"additional","affiliation":[{"name":"Division of Clinical Oncology, Department of Medicine I Medical University of Vienna  Vienna Austria"},{"name":"Comprehensive Cancer Center Medical University of Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Mader","sequence":"additional","affiliation":[{"name":"Division of Clinical Oncology, Department of Medicine I Medical University of Vienna  Vienna Austria"},{"name":"Comprehensive Cancer Center Medical University of Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonhard","family":"M\u00fcllauer","sequence":"additional","affiliation":[{"name":"Clinical Institute of Pathology Medical University Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klikovits","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center Medical University of Vienna  Vienna Austria"},{"name":"Division of Thoracic Surgery, Department of Surgery Medical University of Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bachleitner\u2010Hofmann","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center Medical University of Vienna  Vienna Austria"},{"name":"Division of Visceral Surgery, Department of Surgery Medical University of Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir A.","family":"Hoda","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center Medical University of Vienna  Vienna Austria"},{"name":"Division of Thoracic Surgery, Department of Surgery Medical University of Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald W.","family":"Prager","sequence":"additional","affiliation":[{"name":"Division of Clinical Oncology, Department of Medicine I Medical University of Vienna  Vienna Austria"},{"name":"Comprehensive Cancer Center Medical University of Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2017.03.96"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67025-0"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2018.10.04"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00091"},{"issue":"18","key":"e_1_2_6_6_1","first-page":"319","article-title":"Malignant pleural mesothelioma: Incidence, etiology, diagnosis, treatment, and occupational health","volume":"110","author":"Neumann V","year":"2013","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"e_1_2_6_7_1","first-page":"544","article-title":"MPM: Malignant pleural mesothelioma","volume":"1","author":"Cao C","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00319-2017"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.03.17"},{"issue":"6","key":"e_1_2_6_10_1","first-page":"659","article-title":"Malignant peritoneal mesothelioma: Clinical aspects, and therapeutic perspectives","volume":"31","author":"Boussios S","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw235"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds232"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60868-X"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61121-X"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011573"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.5983"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00391-2017"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26604"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061603"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3520"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2375"},{"issue":"6","key":"e_1_2_6_22_1","first-page":"1227","article-title":"Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer","volume":"55","author":"Sekido Y","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2018.01.005"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/ht7030020"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12199-007-0015-8"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.10.158"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31825f22ee"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.07.105"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.e20030"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30169-9"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.8565"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2018.08.009"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510062"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw413"}],"container-title":["Thoracic Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1759-7714.13491","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1759-7714.13491","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1759-7714.13491","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1759-7714.13491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T13:55:56Z","timestamp":1693922156000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1759-7714.13491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1111\/1759-7714.13491"],"URL":"https:\/\/doi.org\/10.1111\/1759-7714.13491","archive":["Portico"],"relation":{},"ISSN":["1759-7706","1759-7714"],"issn-type":[{"value":"1759-7706","type":"print"},{"value":"1759-7714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,21]]},"assertion":[{"value":"2020-03-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}